Breast cancer drug is lifesaver.
Scotland became the first part of the UK this week to approve Arimidex for post-menopausal women with early breast cancer.
The drug, which has been hailed as the new gold standard therapy after surgery, will benefit around 4,000 women.
Patients in England and Wales could also get the drug before the end of the year.
It is due to be considered soon for approval by the National Institute for Clinical Excellence and become available.
Research published in the Lancet Oncology found women with early breast cancer who switched to Arimidex after using the standard drug Tamoxifen, for two to three years following surgery reduced chances of dying by 29%.
|Printer friendly Cite/link Email Feedback|
|Publication:||Daily Post (Liverpool, England)|
|Date:||Nov 17, 2006|
|Previous Article:||City conservation may save heritage.|
|Next Article:||Liverpool's 'jewel in the crown' synagogue at risk.|
|New hope raised for treatment of cancer.|
|New drug for cancer approved.|
|Volunteer for a vital clinical trial.|